Portal Pump — Peritoneal Insulin Delivery

Type: device

Status: Investigational

Developer: PhysioLogic Devices

Breakthrough Summary

Implantable insulin pump that delivers insulin directly to the peritoneal space. Received FDA Breakthrough Device Designation. Achieves more physiological insulin absorption than subcutaneous delivery.

Mechanism of Action

Implantable insulin pump delivering insulin directly to the peritoneal space, mimicking natural portal insulin delivery

Year: 2026